ArticleNanomedicine (London, England)2024

Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions.

Julia Y Ljubimova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.